These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 3081301
21. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates]. Matsuzaki K, Koyama H, Chiba A, Omika K, Harada S, Sato Y, Hasegawa M, Kobayashi I, Kaneko A, Sasaki J. Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192 [Abstract] [Full Text] [Related]
22. Potent antibacterial activity of oligo-3-aminopyridine against Staphylococcus aureus and Enterococcus faecalis. Akgul C, Kaya I. Indian J Biochem Biophys; 2004 Sep; 41(2-3):120-2. PubMed ID: 22900341 [Abstract] [Full Text] [Related]
23. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution]. Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Tazaki H, Iri H. Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757 [Abstract] [Full Text] [Related]
24. Antibacterial activity of primycin against multiple strains of gram-positive bacteria. Uri JV. Acta Microbiol Hung; 1986 Nov; 33(2):141-6. PubMed ID: 3101392 [Abstract] [Full Text] [Related]
25. In vitro activity of a new 'higher-lactam' antibacterial agent LY 193239. Botha PL, Vorster E, Jordaan C. S Afr Med J; 1991 Mar 16; 79(6):312-3. PubMed ID: 1902004 [Abstract] [Full Text] [Related]
28. Antibacterial activity of ceramide and ceramide analogs against pathogenic Neisseria. Becam J, Walter T, Burgert A, Schlegel J, Sauer M, Seibel J, Schubert-Unkmeir A. Sci Rep; 2017 Dec 15; 7(1):17627. PubMed ID: 29247204 [Abstract] [Full Text] [Related]
29. [Antibacterial activities of new quinolones against fresh clinical isolates]. Deguchi K, Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Oda S, Tanaka S, Nakane Y, Fukumoto T. Jpn J Antibiot; 1994 Oct 15; 47(10):1379-400. PubMed ID: 7807698 [Abstract] [Full Text] [Related]
30. Daptomycin in vitro susceptibility in European Gram-positive clinical isolates. Fluit AC, Schmitz FJ, Verhoef J, Milatovic D. Int J Antimicrob Agents; 2004 Jul 15; 24(1):59-66. PubMed ID: 15225863 [Abstract] [Full Text] [Related]
31. Clinical uses and control of rifampicin and clindamycin. Phillips I. J Clin Pathol; 1971 Jul 15; 24(5):410-8. PubMed ID: 4999067 [No Abstract] [Full Text] [Related]
32. [Clinical laboratory approach to estimating the effective administration dose of imipenem/cilastatin. Evaluation of the disk susceptibility test and its interpretation system]. Matsuo K, Uete T. Jpn J Antibiot; 1989 Nov 15; 42(11):2377-92. PubMed ID: 2621780 [Abstract] [Full Text] [Related]
33. Bactericidal activity of ertapenem against major intra-abdominal pathogens. Borbone S, Cascone C, Santagati M, Mezzatesta ML, Stefani S. Int J Antimicrob Agents; 2006 Nov 15; 28(5):396-401. PubMed ID: 17045463 [Abstract] [Full Text] [Related]
37. In vitro antibacterial activity and beta-lactamase stability of cefodizime, a new cephalosporin antibiotic. Kasai K, Tsuji A, Miyazaki S, Goto S, Fujimoto K, Masuyoshi S, Arai S. Jpn J Antibiot; 1984 Jul 15; 37(7):1294-305. PubMed ID: 6092739 [Abstract] [Full Text] [Related]
38. [In vitro antibacterial activity of ciprofloxacin against uropathogenic organisms]. Allocati N, Catamo G, Cellini L. Boll Soc Ital Biol Sper; 1984 Oct 30; 60(10):1927-33. PubMed ID: 6440583 [Abstract] [Full Text] [Related]
39. Synthesis and evaluation of isatin-β-thiosemicarbazones as novel agents against antibiotic-resistant Gram-positive bacterial species. Zhang XM, Guo H, Li ZS, Song FH, Wang WM, Dai HQ, Zhang LX, Wang JG. Eur J Med Chem; 2015 Aug 28; 101():419-30. PubMed ID: 26185006 [Abstract] [Full Text] [Related]